Trial intelligence / Profile preview

Soluble Corn Fiber Supplementation for Asthma

NCT03673618Phase 2Completed

Sponsor
Phoenix Children's
Start
Sep 2019
Primary completion
Dec 2021
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (2 arms), sponsored by Phoenix Children's. Primary endpoint: Asthma symptoms at 4 weeks. Started Sep 2019; status: completed.

Beyond the preview

Go deeper on NCT03673618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03673618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call